JPMorgan Chase & Co Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.57B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.02B |
| 3 |
Northrop Grumman
NOC
|
+$504M |
| 4 |
Truist Financial
TFC
|
+$493M |
| 5 |
Analog Devices
ADI
|
+$490M |
Top Sells
| 1 |
Alibaba
BABA
|
+$1.87B |
| 2 |
Tesla
TSLA
|
+$1.01B |
| 3 |
Verizon
VZ
|
+$808M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$798M |
| 5 |
TSMC
TSM
|
+$797M |
Sector Composition
| 1 | Technology | 17.8% |
| 2 | Consumer Discretionary | 11.45% |
| 3 | Healthcare | 10.78% |
| 4 | Financials | 10.38% |
| 5 | Industrials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3701
Lifecore Biomedical
LFCR
$281M
| $147K | ﹤0.01% |
15,100
-5,639
| -27% | -$54.9K |
|
|
MOGO
3702
Mogo
MOGO
$45.6M
| $147K | ﹤0.01% |
33,333
| – | – |
|
3703
Prothena Corp
PRTA
$442M
| $147K | ﹤0.01% |
14,789
+1,051
| +8% | +$10.4K |
|
3704
Innovator IBD 50 ETF
FFTY
$80.7M
| $146K | ﹤0.01% |
+3,942
| New | +$146K |
|
3705
JPMorgan Diversified Return US Equity ETF
JPUS
$391M
| $146K | ﹤0.01% |
1,984
-453
| -19% | -$33.3K |
|
3706
Montrose Environmental
MEG
$1.05B
| $146K | ﹤0.01% |
+5,900
| New | +$146K |
|
|
BVH
3707
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $146K | ﹤0.01% |
10,404
-1,569
| -13% | -$22K |
|
3708
AMES National
ATLO
$182M
| $145K | ﹤0.01% |
8,611
-938
| -10% | -$15.8K |
|
3709
Bank of Marin Bancorp
BMRC
$398M
| $145K | ﹤0.01% |
4,950
-9,618
| -66% | -$282K |
|
3710
Mirum Pharmaceuticals
MIRM
$3.73B
| $145K | ﹤0.01% |
7,480
+2,856
| +62% | +$55.4K |
|
3711
MVB Financial
MVBF
$305M
| $145K | ﹤0.01% |
9,329
+45
| +0.5% | +$699 |
|
3712
Navigator Holdings
NVGS
$1.11B
| $145K | ﹤0.01% |
17,844
-6,932
| -28% | -$56.3K |
|
3713
Rigel Pharmaceuticals
RIGL
$681M
| $145K | ﹤0.01% |
6,335
-34,079
| -84% | -$780K |
|
3714
Viking Therapeutics
VKTX
$2.79B
| $145K | ﹤0.01% |
24,442
+2,390
| +11% | +$14.2K |
|
3715
Ardelyx
ARDX
$1.59B
| $144K | ﹤0.01% |
27,233
-175,069
| -87% | -$926K |
|
3716
Guaranty Bancshares
GNTY
$557M
| $144K | ﹤0.01% |
6,446
-387
| -6% | -$8.65K |
|
|
LITS
3717
Lite Strategy, Inc. Common Stock
LITS
$96.2M
| $144K | ﹤0.01% |
2,289
-1,596
| -41% | -$100K |
|
3718
Neurogene
NGNE
$271M
| $144K | ﹤0.01% |
610
+90
| +17% | +$21.2K |
|
3719
Preformed Line Products
PLPC
$979M
| $144K | ﹤0.01% |
2,897
-417
| -13% | -$20.7K |
|
3720
Zentalis Pharmaceuticals
ZNTL
$107M
| $144K | ﹤0.01% |
4,297
+820
| +24% | +$27.5K |
|
3721
SPDR S&P 600 Small Cap Growth ETF
SLYG
$3.56B
| $143K | ﹤0.01% |
2,420
| – | – |
|
|
AMTI
3722
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $143K | ﹤0.01% |
+4,629
| New | +$143K |
|
3723
Amneal Pharmaceuticals
AMRX
$3.14B
| $142K | ﹤0.01% |
36,973
+3,391
| +10% | +$13K |
|
|
AYX
3724
DELISTED
Alteryx, Inc.
AYX
| $142K | ﹤0.01% |
1,251
-7,788
| -86% | -$884K |
|
3725
Smith Micro Software
SMSI
$14.7M
| $141K | ﹤0.01% |
4,724
+3,318
| +236% | +$99K |
|